WI
AERI

WrapManager Inc’s Aerie Pharmaceuticals AERI Stock Holding History

WrapManager Inc’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-39,988
Closed -$300K – 298
2022
Q2 		$300K Sell
39,988
-2,744
-6% -$19.3K 0.09% 216
2022
Q1 		$389K Buy
42,732
+9,643
+29% +$74.3K 0.1% 193
2021
Q4 		$232K Sell
33,089
-3,997
-11% -$41.8K 0.06% 280
2021
Q3 		$423K Buy
37,086
+7,752
+26% +$113K 0.11% 179
2021
Q2 		$470K Sell
29,334
-821
-3% -$14.1K 0.12% 177
2021
Q1 		$539K Sell
30,155
-12,203
-29% -$211K 0.15% 144
2020
Q4 		$572K Buy
42,358
+4,019
+10% +$48.6K 0.17% 138
2020
Q3 		$451K Buy
38,339
+12,978
+51% +$158K 0.15% 150
2020
Q2 		$374K Buy
25,361
+14,480
+133% +$214K 0.14% 160
2020
Q1 		$147K Buy
+10,881
New +$206K 0.07% 211

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WrapManager Inc's AERI Position: Q3 2022 in Review

WrapManager Inc sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 39,988 shares — an estimated $300K sold.

WrapManager Inc first reported a position in AERI in Q1 2020 and held it in 10 quarters. The position peaked at $572K in Q4 2020. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • WrapManager Inc reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • WrapManager Inc sold 39,988 Aerie Pharmaceuticals shares in Q3 2022, an estimated $300K.
  • WrapManager Inc first reported a position in Aerie Pharmaceuticals in Q1 2020 and held it in 10 quarters.
  • WrapManager Inc's Aerie Pharmaceuticals position peaked at $572K in Q4 2020.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on WrapManager Inc's 13F filing for Q3 2022, filed 14 Nov 2022.